Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.
Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist. Leuprolide acetate is approved for palliative treatment of advanced Prostate cancer.
Gemcitabine is a cytidine analogue which was hailed as a futuristic anticancer drug when it was first approved for pancreatic cancer towards the end of the 20th century.
Cyclophosphamide is among the older alkylating agents which has stood the test of time. Its proven benefits in a wide variety of cancers, including haematological malignancies, has made it an irreplaceable component of innumerous chemotherapy regimens. Cyclophosphamide is used in both malignant as well as non-malignant disease.
Pemetrexed is among the promising discoveries of the 21st century that changed treatment paradigm for a sub-population of lung cancer patients.
Etoposide is a chemotherapeutic drug that has stood the test of time. It is used extensively in chemotherapy regimens for small cell lung cancer (SCLC), germ cell tumours, neuroblastoma and haematological malignancies like acute leukemias and lymphomas.
Carboplatin is a platinum compound that is preferred to cisplatin by virtue of its better toxicity profile.
Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer.
Docetaxel is the only other member of the taxane family of cancer chemotherapeutic drugs besides paclitaxel.